Skip to reading
Peak Health Peptides

Put the peptide words into everyday sentences

Peptide, hormone, analogue: a few words can make a simple question feel like homework. We’ll keep the useful ones and explain them as we go.

One runner passes a plain baton into another runner's waiting hand.
A baton changes hands, carrying the relay on.

Peptide tells us what something is made of

An amino acid is a building block of protein. A peptide is a short chain of those blocks. Insulin is one example. That puts very different substances under the same broad name.

Hormones are one way the body sends chemical messages. Some peptides are hormones, but knowing that something carries a message doesn’t tell us whether taking a medicine related to it will help. We still need evidence about that medicine and the problem it is meant to address.

We like to finish the sentence when the word gets vague. “A peptide for health” could mean almost anything. “A medicine studied for this condition” gives us something to read about. It also makes it easier to notice when an explanation has skipped a step.

A modified copy is still a different substance

An analogue is a modified version of another molecule. Semaglutide is an analogue of GLP-1, a gut hormone involved in appetite and blood sugar. It acts on the same receptor, a place where a chemical message attaches and has an effect. The medicine label describes that action.

Tirzepatide acts on two kinds of receptor, GIP and GLP-1. There’s no need to memorise those initials here. The useful distinction is between explaining how a substance acts and showing that it helps people with a particular health problem.

We’d keep that distinction even if a description sounds reassuring. “Related to something in the body” is a biological fact. It isn’t a finished answer about benefits or safety.

A study needs a comparison and some context

A placebo is a comparison treatment without the active medicine being tested. In a semaglutide weight-management trial, adults receiving the medicine lost more weight than those receiving placebo. They had obesity, or overweight with a related health condition, and did not have diabetes. Both groups also received lifestyle support.

That tells us what happened in that setting. It doesn’t predict an individual result. A study in cells or animals is a different kind of evidence again; we can’t quietly swap it for a finding in people.

Safety needs the same care. Semaglutide commonly causes stomach problems. Its boxed warning, the FDA’s strongest kind, concerns thyroid tumours seen in rodents; whether they occur in people is unknown. From here, body and treatment puts the categories together, and everyday evidence shows where answers are still missing.